发明名称 |
Combination of direct acting antiviral agents and ribavirin for treating HCV patients |
摘要 |
<p>The present invention features interferon -free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of interferon, and said at least two direct acting antiviral agents comprise (a) Compound 1 and (b) Compound 2 or a pharmaceutically acceptable salt thereof as disclosed in the description.</p> |
申请公布号 |
AU2014239322(A1) |
申请公布日期 |
2015.08.27 |
申请号 |
AU20140239322 |
申请日期 |
2014.03.14 |
申请人 |
ABBVIE INC. |
发明人 |
BERNSTEIN, BARRY M.;DUTTA, SANDEEP;LIU, WEI;PODSADECKI, THOMAS J.;CAMPBELL, ANDREW L.;MENON, RAJEEV M.;LIN, CHIH-WEI;WANG, TIANLI;AWNI, WALID M. |
分类号 |
A61K31/454;A61K31/4985;A61K31/7056;A61K45/06;A61P31/22 |
主分类号 |
A61K31/454 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|